These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1491 related items for PubMed ID: 8865912
1. Effect of CAPD and hemodialysis on parathyroid function. Malberti F, Corradi B, Imbasciati E. Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912 [Abstract] [Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
3. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group. Weinreich T, Ritz E, Passlick-Deetjen J. Perit Dial Int; 1996 Nov; 16(3):260-8. PubMed ID: 8761540 [Abstract] [Full Text] [Related]
4. Low calcium (1.25 mmol/L) dialysate can normalize relative hypoparathyroidism in CAPD patients with low bone turnover. Shigematsu T, Kawaguchi Y, Kubo H, Nakayama M, Kato N, Yamamoto H, Osaka N, Hayakawa H, Ogawa A, Sakai O. Adv Perit Dial; 1996 Nov; 12():250-6. PubMed ID: 8865914 [Abstract] [Full Text] [Related]
5. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone. Bro S, Brandi L, Olgaard K. Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216 [Abstract] [Full Text] [Related]
6. Long-term effect of oral calcitriol single weekly pulse in CAPD and in HD. Romanini D, Gazo A, Bellazzi R, de Vincenzi A, Nai M, Santagostino M. Adv Perit Dial; 1994 Aug; 10():267-9. PubMed ID: 7999842 [Abstract] [Full Text] [Related]
7. A randomized trial comparing 1.25 mmol/l calcium dialysate to 1.75 mmol/l calcium dialysate in CAPD patients. Johnson DW, Rigby RJ, McIntyre HD, Brown A, Freeman J. Nephrol Dial Transplant; 1996 Jan; 11(1):88-93. PubMed ID: 8649658 [Abstract] [Full Text] [Related]
8. Control of parathyroid function in patients with a short history of hemodialysis. Nishi H, Sato T, Kurihara T, Kurosawa T, Fukagawa M. Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904 [Abstract] [Full Text] [Related]
9. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group. Weinreich T, Passlick-Deetjen J, Ritz E. Am J Kidney Dis; 1995 Mar; 25(3):452-60. PubMed ID: 7872324 [Abstract] [Full Text] [Related]
10. Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis. Greenbaum LA, Grenda R, Qiu P, Restaino I, Wojtak A, Paredes A, Benador N, Melnick JZ, Williams LA, Salusky IB. Pediatr Nephrol; 2005 May; 20(5):622-30. PubMed ID: 15785941 [Abstract] [Full Text] [Related]
11. Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism. Malberti F, Corradi B, Cosci P, Calliada F, Marcelli D, Imbasciati E. Am J Kidney Dis; 1996 Nov; 28(5):704-12. PubMed ID: 9158208 [Abstract] [Full Text] [Related]
12. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients. Navarro JF, Mora C, Macia M, Garcia J. Perit Dial Int; 1999 Nov; 19(5):455-61. PubMed ID: 11379859 [Abstract] [Full Text] [Related]
13. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Qi Q, Monier-Faugere MC, Geng Z, Malluche HH. Am J Kidney Dis; 1995 Oct; 26(4):622-31. PubMed ID: 7573017 [Abstract] [Full Text] [Related]
14. Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. Torres A, Lorenzo V, Hernández D, Rodríguez JC, Concepción MT, Rodríguez AP, Hernández A, de Bonis E, Darias E, González-Posada JM. Kidney Int; 1995 May; 47(5):1434-42. PubMed ID: 7637272 [Abstract] [Full Text] [Related]
15. Serum markers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis. Avila-Díaz M, Matos M, García-López E, Prado MD, Castro-Vázquez F, Ventura MD, González E, Amato D, Paniagua R. Perit Dial Int; 2006 May; 26(1):78-84. PubMed ID: 16538879 [Abstract] [Full Text] [Related]
16. The sigmoidal parathyroid hormone-ionized calcium curve and the set point of calcium in hemodialysis and continuous ambulatory peritoneal dialysis. Malberti F, Corradi B, Pagliari B, Romanini D, Gazo A, Sidoti A, Baretta A, Bellazzi R, Imbasciati E. Perit Dial Int; 1993 May; 13 Suppl 2():S476-9. PubMed ID: 8399645 [Abstract] [Full Text] [Related]
17. Effects of subcutaneous calcitriol administration on plasma calcium and parathyroid hormone concentrations in continuous ambulatory peritoneal dialysis uremic patients. Rolla D, Paoletti E, Marsano L, Mulas D, Peloso G, Cannella G. Perit Dial Int; 1993 May; 13(2):118-21. PubMed ID: 8494932 [Abstract] [Full Text] [Related]
18. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis. Mottet JJ, Horber FF, Casez JP, Descoeudres C, Jaeger P. J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702 [Abstract] [Full Text] [Related]
19. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V, Torregrosa V. Nefrologia; 2008 Jan; 28 Suppl 3():67-78. PubMed ID: 19018742 [Abstract] [Full Text] [Related]
20. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate. Cho MS, Lee KS, Lee YK, Ma SK, Ko JH, Kim SW, Kim NH, Choi KC. Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088 [Abstract] [Full Text] [Related] Page: [Next] [New Search]